It is time to take stock, reflect on the past few years and plan for the future of the journal. Every year at Palliative Medicine, we have both editorial and editorial advisory board meetings where we appraise the journal and think about the following years. These are important meetings and enable reflection on the views of readers, authors and reviewers met and interacted with through the year. This editorial is an attempt to communicate some of that thinking more widely and to generate a debate about how you want the journal to move forwards.
The function of a modern healthcare journal in the information age we currently live within is complex. There is an expectation that accessible and useable information is available at the click of a button or the swipe of a finger. Does a traditional journal like Palliative Medicine based on a print-based publication model meet that need? Well, yes and no. Our papers are not always as rapidly processed or available to readers as we would like, but we balance speed and availability against other important functions such as authority, aggregation, accessibility and utility. We invite you to join the debate on our response to these considerations.
We want Palliative Medicine to be seen as an authoritative source of information relevant to our broad international multidisciplinary field of work: the 'go to' destination to find high-quality palliative care research. Our primary purpose remains the dissemination of excellent research to guide clinical practice, research, theory and methods. The editorial and review processes we put in place are to facilitate the publication of only the highest quality of work submitted to us. This means disappointment for authors whose work we don't publish, but the decision to decline a paper is not taken lightly. Each paper submitted is read by a number of editors before a decision about whether it enters the peer review and revision systems. Such quality assurance systems do, however, create delay. Response times are improving, and our time to final decision has decreased by 25% in the last few years. We do urge reviewers to respond swiftly to requests to review (even if the answer is no), as this part of the system continues to be where delays creep in. Do please consider joining us as a reviewer to contribute to the quality of published research and help us to facilitate a speedier response for all. It's not a perfect system, the issues inherent in peer review systems are well rehearsed, we don't always get it right, but we believe that it has led to the publication of higher quality papers.
We take forward papers that we believe add to knowledge in our field, are relevant to our readership in Palliative Medicine, methodologically sound and which have a clearly articulated message relevant to an international readership. We are keen to publish any high-quality work relevant to palliative care. One of the most common conversations editors have with authors is about the type of paper we publish. Please don't be constrained by thinking that 'they have never published a paper on x, so I'll send it elsewhere'. We might be very interested, but rarely receive papers relating to that topic. We usually give initial feedback on papers (to decline or send for review) within 21 days or less, so you should know quickly if we are interested in the area. Alternatively, we are happy to receive an abstract via email for us to check whether we consider your topic to be within scope for the journal.
We work closely with authors to try and ensure that research is aggregative. We now ask authors to explicitly state 'what is already known' and 'what this paper adds' as simple clear statements to ensure readers understand how work adds to existing knowledge, policy and practice. We encourage structured discussion sections which make it clear where research fits within an international knowledge base. We have pursued a policy of trying to group papers which address a similar issue together and inviting an expert to consider the current debates and the direction of travel for research in that field within an editorial. In addition, we have instigated annual themed special editions with invited expert guest editors. These have included editions on non-malignant disease, family carers, critical care and the forthcoming edition on integrated palliative care. We welcome suggestions for future editions. These ways of working are what we hope makes Palliative Medicine a distinctive way of disseminating research that can be rapidly assimilated within the expanding amounts of information available to readers.
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Editorial Palliative Medicine 29 (8) of Palliative Medicine is the widespread dissemination of information to audiences who would have the best use of that knowledge and can use it to make a difference to patients, practice and policy. We are addressing discoverability through working with authors on titles, structured abstracts and keywords to enhance retrieval through different platforms. We have an active social media presence through twitter (@palliativemedj) and Facebook, and our authors contribute regularly to the European Association of Palliative Care (EAPC) blog. We can see that this helps us to engage with a broad international audience who perhaps might not otherwise access the work that we publish. Do follow us, it is important to us and a way for you to engage directly in conversations with us.
As editors we monitor and engage in debates about how journal publishing is funded and the particular issues of paywalls. We facilitate the widest possible access to the papers that we publish through a number of initiatives. Our publishers support the HINARI initiative which gives free or greatly reduced price access to institutions in low-and middle-income countries. Palliative Medicine is designated as RoMEO green, which enables researchers to archive post-print drafts in institutional or other repositories to enable wider access. Our 'editors choice' papers are available to registered users of the EAPC website. Open access publishing is possible within our current model and is an option increasingly taken up by authors, especially as it is mandated by a number of research funders. However, we have to be mindful of the 'mixed economy' of research in palliative care which makes an open access funding model challenging for some researchers. For example, of the research we published in 2014, while most was funded by national or local research grants (60%) and a proportion from international funding sources (12%), a substantial number of papers (28%) did not identify a source of funding for their work.
We monitor how we meet the needs of our authors and readers in a number of ways. Pleasingly, the number of paper downloads from the website continues to grow rapidly, we can see that people access the website from virtually every country in the world and the Altmetrics for the journal are some of the highest in the field. Our impact factor continues to rise, although we have moved to publish more papers each year as part of our move to 10 editions a year. All of these metrics have flaws, but they remain a way of understanding if we continue to publish papers which are relevant and important to palliative care.
So what next? We plan to continue to pursue policies which we think will lead to the publication, dissemination and use of the highest possible quality of research to guide the development of palliative care. We are open to suggestions from you, our readers, authors and reviewers, on what you would like to see and how you want us to grow and develop. You are at the cutting edge of palliative care research and practice in multiple contexts and situations that we may never have encountered. Help us to understand your needs and how best to meet them, and we will do our best to respond so that we continue to be a journal that meets the needs of our specialty. You can contact us by email, via twitter or Facebook, or when you meet us -you can see the full list of editors and members of the editorial advisory board in print or online.
